NextCure Statistics

Total Valuation

NextCure has a market cap or net worth of $47.27 million. The enterprise value is -$42.95 million.

Market Cap	47.27M
Enterprise Value	-42.95M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, after market close.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

NextCure has 27.97 million shares outstanding. The number of shares has increased by 0.46% in one year.

Shares Outstanding	27.97M
Shares Change (YoY)	+0.46%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	8.85%
Owned by Institutions (%)	58.64%
Float	19.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.70, with a Debt / Equity ratio of 0.06.

Current Ratio	10.70
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -53.30% and return on invested capital (ROIC) is -65.70%.

Return on Equity (ROE)	-53.30%
Return on Assets (ROA)	-47.50%
Return on Capital (ROIC)	-65.70%
Revenue Per Employee	n/a
Profits Per Employee	-$777,244
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.98% in the last 52 weeks. The beta is 0.67, so NextCure's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-3.98%
50-Day Moving Average	1.57
200-Day Moving Average	1.44
Relative Strength Index (RSI)	55.68
Average Volume (20 Days)	70,936

Short Selling Information

The latest short interest is 98,936, so 0.35% of the outstanding shares have been sold short.

Short Interest	98,936
Short Previous Month	70,100
Short % of Shares Out	0.35%
Short % of Float	0.52%
Short Ratio (days to cover)	1.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.87M
Pretax Income	-63.73M
Net Income	-63.73M
EBITDA	-59.65M
EBIT	-63.73M
Earnings Per Share (EPS)	-$2.28

Full Income Statement

Balance Sheet

The company has $96.00 million in cash and $5.77 million in debt, giving a net cash position of $90.23 million or $3.23 per share.

Cash & Cash Equivalents	96.00M
Total Debt	5.77M
Net Cash	90.23M
Net Cash Per Share	$3.23
Equity (Book Value)	99.05M
Book Value Per Share	3.54
Working Capital	92.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$50.80 million and capital expenditures -$609,000, giving a free cash flow of -$51.41 million.

Operating Cash Flow	-50.80M
Capital Expenditures	-609,000
Free Cash Flow	-51.41M
FCF Per Share	-$1.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NextCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.46%
Shareholder Yield	-0.46%
Earnings Yield	-134.82%
FCF Yield	-108.75%

Analyst Forecast

The average price target for NextCure is $6.00, which is 255.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	255.03%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.98%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2